Bath & Body Works has seen a long slide in its share price over recent years, and the key issue now is how well the current US$17.71 level lines up with the cash the business can generate. With a Discounted Cash Flow (DCF) view available, the question for you is whether the stock price today is fully explained by those cash flows or asking more of them.
-
The share price has fallen 69.4% over 5 years, which puts the focus squarely on whether the underlying cash generation still supports a long term investment case.
-
Bath & Body Works leans heavily on its ability to convert store and online sales into free cash, so any change in margins or capital spending plans can shift what its cash flows are worth to you today.
-
If you'd rather focus on earnings, this one's for you. See what Bath & Body Works's 4.6x P/E says about the price .
The issue now is whether the current market price for Bath & Body Works fairly reflects the cash flows that investors expect the business to produce over time.
To see how Bath & Body Works compares with other companies where valuation and cash generation are also in focus, view it alongside 27 high quality undervalued stocks .
Is Bath & Body Works a Bargain on Cash Flow?
The Discounted Cash Flow (DCF) model here is built on the cash that Bath & Body Works can return to shareholders over time. The business produced trailing twelve month free cash flow of about $1,049.3 million, which is a sizeable pool of cash against a share price of $17.71. That gives you a starting point where the company is already generating material cash today rather than relying purely on distant expectations.
Analysts feeding into this DCF expect free cash flow in future years to trend below the latest level, with the projections pointing to gently declining annual figures before settling into smaller growth rates. Even with that softer path for cash generation, the model still arrives at an estimated intrinsic value that the DCF projections suggest is substantially above the current market price of $17.71. For anyone weighing Bath & Body Works against other options, the key question is whether those assumed cash flows feel conservative enough for the risk you are taking. Find out what Bath & Body Works could be worth using our Discounted Cash Flow (DCF) estimate .
The Bath & Body Works Narrative: What Would Justify Today's Price?
Narratives pick up where the Bath & Body Works valuation puzzle leaves off by spelling out what mix of future growth, profitability and earnings power would need to play out for the stock to be worth meaningfully more or less than today's price on Simply Wall St's Community page. Each storyline links its number back to a clear view on how Bath & Body Works' growth profile, margins and risk picture could shift, giving you something specific to revisit as fresh information arrives.
Bath & Body Works splits opinion in the community, with one camp seeing more upside in the story than the other.
Bull case: 38% undervalued
"The firm has rolled out a new customer loyalty app nationally, at last disclosure, it has attracted 37 million active members that comprise 80% of US sales…"
Discover why this Narrative puts Bath & Body Works at 38% undervalued .
Bear case: roughly fairly valued
"While Bath & Body Works is seeing owned digital return to growth and improve new customer conversion, the 5.4% decline in U.S. and Canadian store net sales and continued store traffic softness suggest digital and omnichannel gains may not be enough to offset pressure on the larger physical store base…"
Explore why this Narrative puts Bath & Body Works at roughly fairly valued .
The Bath & Body Works price is only one piece of the decision
Valuation tells you what you might be paying, but Simply Wall St's broader checks on Bath & Body Works have also flagged potential concerns that deserve a closer look before you rely on the numbers alone. Take a closer look at 3 warning signs (1 major) before settling on a valuation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BBWI .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
